Advancing cancer immunotherapy: Small-Molecule, biomacromolecular, and nanoscale PROTACs targeting PD-L1 for degradation
Programmed death-ligand 1 (PD-L1) is a key immune checkpoint protein that enables tumor immune evasion by engaging PD-1 on T cells, thereby inhibiting their cytotoxic function. Although immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis have marked a breakthrough in cancer therapy, th...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2025-08-01
|
| Series: | Materials Today Advances |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2590049825000517 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|